These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3723511)

  • 1. Nifedipine and distal gangrene in Raynaud's phenomenon.
    Rivera Redondo J; Noguerado Asensio A; Alvaro-Gracia Alvaro JM; Laffón Roca A
    J Rheumatol; 1986 Apr; 13(2):464-5. PubMed ID: 3723511
    [No Abstract]   [Full Text] [Related]  

  • 2. Iloprost treatment of finger gangrene in a patient with Raynaud's syndrome.
    Levy Y; Sherer Y; Shoenfeld Y
    Isr Med Assoc J; 2000 Dec; 2(12):960-1. PubMed ID: 11344792
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of nifedipine in Raynaud's phenomenon associated with systemic sclerosis.
    Thakur SK; Gopinathan VP; Jagdish TK; Bhalla IP; Shetty KJ
    J Assoc Physicians India; 1986 Jul; 34(7):536. PubMed ID: 3759897
    [No Abstract]   [Full Text] [Related]  

  • 4. Nifedipine treatment of Raynaud's phenomenon in a paediatric age.
    Matucci Cerinic M; Falcini F; Bartolozzi G; Volpi M
    Int J Clin Pharmacol Res; 1985; 5(1):67-9. PubMed ID: 3997315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syncope and Raynaud's disease.
    Guiloff RJ; Rajakulendran S; Angus-Leppan H
    Arch Neurol; 2012 May; 69(5):608-13. PubMed ID: 22248476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of nifedipine in patients with Raynaud's phenomenon].
    Rozwodowska M; Polaszewska-Muszyńska M; Ukleja-Adamowicz M; Rewakowicz M; Guzowska M; Marunowska A; Jundziłł W; Wodyńska T; Ruchalski M; Strzelecki A
    Kardiol Pol; 1987; 30 Suppl():97-105. PubMed ID: 3331405
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of nifedipine (Adalat) on Raynaud's phenomenon].
    Baadsgaard O; Schmidt JF; Ironmann L
    Ugeskr Laeger; 1983 Dec; 145(49):3814-6. PubMed ID: 6364517
    [No Abstract]   [Full Text] [Related]  

  • 8. Raynaud's phenomenon and nifedipine.
    Kraus A
    J Rheumatol; 1989 Jul; 16(7):1013. PubMed ID: 2597264
    [No Abstract]   [Full Text] [Related]  

  • 9. DIAS rounds. Nifedipine and prazosin in Raynaud's phenomenon.
    Pisenti L; Hart LL
    Drug Intell Clin Pharm; 1984 Mar; 18(3):213-4. PubMed ID: 6365494
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
    Sauza J; Kraus A; González-Amaro R; Alarcón-Segovia D
    J Rheumatol; 1984 Jun; 11(3):362-4. PubMed ID: 6376801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Capillaroscopic evaluation of the effects of nifedipine in patients with Raynaud's phenomenon].
    Riccio A; Pennarola R; Farinaro C; Scherillo G; Infranzi E; Del Puente A; Oriente P
    Clin Ter; 1988 May; 125(3):185-90. PubMed ID: 2973939
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the efficacy of the treatment of Raynaud's phenomenon with nifedipine by laser-Doppler flowmetry.
    Belcaro GV; Gabini M; Cacchio M
    Panminerva Med; 1987; 29(3):223-7. PubMed ID: 2962057
    [No Abstract]   [Full Text] [Related]  

  • 13. [Raynaud's phenomena of carpal origin. Recovery of a gangrenous form of Raynaud's disease with a local corticotherapy in the carpal canal].
    Rageot E; Maigne R; Nataf J
    Angeiologie; 1970; 22(4):233-5. PubMed ID: 5454595
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of nifedipine in Raynaud's disease: a case report.
    Maguire FW
    Del Med J; 1984 Jul; 56(7):393-8. PubMed ID: 6479385
    [No Abstract]   [Full Text] [Related]  

  • 15. Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon.
    Fisher J; Mack RJ; Likier HM; Schiff AN; Borer JS
    Chest; 1987 Sep; 92(3):400-5. PubMed ID: 3622018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketanserin versus nifedipine in secondary Raynaud's phenomenon.
    Kirch W; Linder HR; Hutt HJ; Ohnhaus EE; Mahler F
    Vasa; 1987; 16(1):77-80. PubMed ID: 3554811
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effects.
    Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
    Vasa Suppl; 1987; 18():68-70. PubMed ID: 3299818
    [No Abstract]   [Full Text] [Related]  

  • 18. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
    Kahan A; Weber S; Amor B; Menkes CJ; Hodara M; Degeorges M
    Int Angiol; 1985; 4(2):221-3. PubMed ID: 3831143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of longterm nifedipine in a patient with Raynaud's syndrome secondary to mixed connective tissue disease.
    Sarkozi J; McCarthy DD; Lee P
    J Rheumatol; 1984 Jun; 11(3):408-10. PubMed ID: 6737386
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of nifedipine therapy on pulmonary Raynaud's in primary Sjögren's syndrome.
    Joseph BZ; Organek HW; Grant A; Axelrod DA
    Clin Exp Rheumatol; 1988; 6(4):409-10. PubMed ID: 3229032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.